Company · CIK 0000715446 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Anixa Biosciences Inc · ANIX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 PForm 4 → | Sep 25, 8:39 am EDT | Lewis H Titterton Jr.Director | 49,036 | $2.69 | $131,907 | 1,046,003 | +4.92% | |
| Sep 10, 2026 PForm 4 → | Sep 14, 9:45 am EDT | Amit KumarChief Executive Officer, Director | 3,000 | $2.75 | $8,250 | 665,000 | +0.45% | |
| Sep 10, 2026 PForm 4 → | Sep 14, 9:15 am EDT | Lewis H Titterton Jr.Director | 10,000 | $2.73 | $27,300 | 996,967 | +1.01% | |
| Sep 10, 2026 PForm 4 → | Sep 11, 8:00 am EDT | Amit KumarChief Executive Officer, Director | 5,000 | $2.76 | $13,800 | 662,000 | +0.76% |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.